BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahn CH, Lee WW, Jung YC, Shin JA, Hong KO, Choi S, Swarup N, Kim J, Ahn MH, Jung M, Cho SD, Jin B. Antitumor effect of TW-37, a BH3 mimetic in human oral cancer. Lab Anim Res 2019;35:27. [PMID: 32257914 DOI: 10.1186/s42826-019-0028-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Melo G, Silva CAB, Hague A, Parkinson EK, Rivero ERC. Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge. Oral Oncol 2022;132:105979. [PMID: 35816876 DOI: 10.1016/j.oraloncology.2022.105979] [Reference Citation Analysis]
2 Yang IH, Hong SH, Jung M, Ahn CH, Yoon HJ, Hong SD, Cho SD, Shin JA. Cryptotanshinone chemosensitivity potentiation by TW-37 in human oral cancer cell lines by targeting STAT3-Mcl-1 signaling. Cancer Cell Int 2020;20:405. [PMID: 32863764 DOI: 10.1186/s12935-020-01495-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ichimura T, Mori Y, Aschauer P, Padmanabha Das KM, Padera RF, Weins A, Nasr ML, Bonventre JV. KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney. medRxiv 2020:2020. [PMID: 32995803 DOI: 10.1101/2020.09.16.20190694] [Cited by in Crossref: 14] [Article Influence: 7.0] [Reference Citation Analysis]
4 Dou Z, Zhao D, Chen X, Xu C, Jin X, Zhang X, Wang Y, Xie X, Li Q, Di C, Zhang H. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation. J Exp Clin Cancer Res 2021;40:194. [PMID: 34118966 DOI: 10.1186/s13046-021-02001-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Yu R, Lu Y, Yu R, Xie J, Zhou S. Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells. Cancer Manag Res 2021;13:953-63. [PMID: 33568941 DOI: 10.2147/CMAR.S265788] [Reference Citation Analysis]